ACELYRIN acquires ValenzaBio, strengthens immunology positio...

ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area,

How to get acquisition ready – a seller’s guide to merger an...

This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we near the end of the year, there were some big moves.

Solid Biosciences acquires AavantiBio, conducts $75 million ...

The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a

Welcoming analytics-driven digital marketing agency closerlo...